APOA1 and cancer: As the primary protein component of high-density lipoproteins (HDL), apolipoprotein A1 (APOA1) levels may enable better prediction of an individual's cancer risk, earlier diagnosis of malignancy, tracking of disease progression during follow-up, and stratification of patients based on likely prognosis [31].